The 9th World Orphan Drug Congress is Europe's meeting place for the rare disease community. The Conference offers strategic keynote plenaries, themed tracks and dedicated networking sessions, you have the chance to really tailor the event to the needs of your day-to-day role.
Exhibitors have a unique opportunity to put their business products and services in front of potential buyers looking to source the latest technologies in the orphan drugs industry. Meet and listen to biotech start-ups and investors in our Pitch & Partner track where the most promising companies showcase their orphan drug technology and pipeline.
The Congress was one of the first events to bring together the full range of stakeholders and influencers in the orphan drug and rare disease sector, from the pharma and biotechs to patient advocates and representatives from payers.
It continues to be a key meeting for the sector in pushing forward with strategy, advocacy and partnering within the rare disease space. Now recognised as the largest and most established European orphan drug event, we are once again proud to deliver another fantastic speaker line up and content filled agenda that represents the whole orphan drug scene. The 9th annual event will address the strategic and commercial aspects of bringing new treatments to patients who suffer from rare diseases.
For 2018 we will be expanding the meeting further in our new Eastern European setting, offering more dedicated content and tracks than ever before on Clinical Development, Market Access, Science & Strategy, Pitch & Partner and Cell & Gene Therapy.
View the latest speaker line-up and agenda here https://goo.gl/WmZm3e
Conference Only (Final Price): EUR 3315
Conference Academic & Regulatory (Final Price): EUR 1660
Conference + Workshops (Final Price): EUR 3815
Conference + Workshops Academic & Regulatory (Final Price): EUR 2160
Venue details:Crowne Plaza Hotel Barcelona, Av. de Rius i Taulet, 1, 08004, Barcelona, Spain